91�鶹����ֱ��

The drug lenacapavir, developed by Gilead Sciences, provides protection for half a year instead of one day and has performed extremely well in clinical trials.

Synthetic organisms, mirror-reversed on the molecular level from natural life, could be a possibility within decades. They could interact with humans and the environment in unpredictable, potentially dangerous ways.

The therapy increases the amount of blood the heart can pump and dramatically improves survival, in what a paper describing the results calls “an unprecedented recovery of cardiac function.”

NASA crew and ground-based scientists are sending blood cells to the International Space Station on November 4 to learn why astronauts have a higher risk of blood clots.

Preventing the protein's activity causes parasites to die unusually rapidly.

91�鶹����ֱ�� approached a half-billion dollars ($492.3 million) in research funding in fiscal year 2024. Research in the health sciences has been on a growth trajectory more than...

Scientists are finding clues for how to treat diabetes and hormone disorders in an unexpected place: a toxin from one of the most venomous animals on the planet.

An AI-based analysis of over 2 million hospital visits has found that more often than not, a pneumonia diagnosis will change over the course of a patient's stay.

For people with long COVID, symptoms can last months or even years, making a return to normal life feel impossible. Who's at risk, and what treatments are available?

The new results could ultimately help lead to interventions that help spark creative thought or aid people who have mental illnesses that disrupt these regions of the brain.

They're more than a simple clock, and understanding these cells' activity could ultimately aid in early detection of neurodegenerative diseases.

New recordings capture, for the first time, the internal acrobatics behind the harsh vocals of deathcore music.

A new study led by scientists at 91�鶹����ֱ�� demonstrates that it is possible to impact health and behavior by manipulating the gut microbiome in a controlled way.

Spinocerebellar ataxia 4 is a severe progressive movement disease that can begin as early as the late teens. Now, a multinational research team led by University of Utah researchers has...

Medicinal chemist Amy Barrios and developmental biologist H. Joseph Yost received this lifetime honor, celebrating their excellence in research and commitment to mentoring the next generation of scientists.